Neuropsychological Deficits

How it works

Risks & contraindications

Highlighted claims

• Both ADHD and addictive disorders involve executive dysfunction affecting working memory, inhibitory control and cognitive flexibility. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
• Both conditions also involve impaired attention modulation and memory difficulties. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
• Even mild neuropsychological deficits predict treatment dropout in both ADHD and addictive disorders. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
• Neuropsychological deficits associated with addictive disorders may worsen attention deficits and reduce compensatory capacity. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
• The link between ADHD and addictive disorders may involve shared neuropsychological traits and genetic or epigenetic vulnerability. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol